Published on in Vol 8, No 1 (2022): January
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/33311, first published
.
![Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study](https://asset.jmir.pub/assets/ddf3fddf2e4a5dabfa57220dc325d391.png 480w,https://asset.jmir.pub/assets/ddf3fddf2e4a5dabfa57220dc325d391.png 960w,https://asset.jmir.pub/assets/ddf3fddf2e4a5dabfa57220dc325d391.png 1920w,https://asset.jmir.pub/assets/ddf3fddf2e4a5dabfa57220dc325d391.png 2500w)
Journals
- Kang D, Kim S, Kim H, Lee M, Kong S, Chang Y, Sim S, Kim Y, Cho J. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study. JMIR Public Health and Surveillance 2023;9:e44105 View
- Sarker J, Carkovic E, Ptaszek K, Lee T. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024;44(5):383 View
- Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The value of social media analysis for adverse events detection and pharmacovigilance: a Scoping Review (Preprint). JMIR Public Health and Surveillance 2024 View